Is Apellis covered by insurance?
Treatments developed and commercialized by Apellis Pharmaceuticals, such as specialized therapies for rare diseases, are generally subject to varying levels of coverage and prior authorization requirements by commercial health insurance providers and government programs. Because these specialty medications address complex, uncommon medical conditions, navigating insurance approvals requires close coordination with specialized patient support programs like ApellisAssist, which helps manage verification, copay assistance, and temporary bridge supplies during coverage transitions. Patients are strongly advised to consult their specific insurance plans and care coordinators to understand out-of-pocket costs and formulary inclusions.
Related FAQs
Yes, Bitdeer Technologies Group announced that it had sold its entire Bitcoin treasury, including reserves and weekly production, bringing its Bitcoin balance to zero as of February 20, 2026.
Aperam S.A. employs more than 13,000 professionals globally across its advanced stainless steel, specialty alloys, recycling, and renewable energy operations.
In 2007, prior to its corporate name change from Research In Motion (RIM) and before the widespread market disruption caused by modern smartphones, BlackBerry stock experienced an explosive multi-year bull run.
Employee reviews, workplace culture evaluations, and corporate feedback platforms indicate that Apellis Pharmaceuticals is generally regarded as a rewarding and progressive place to build a career within the biotechnology and biopharmaceutical sec...
Apellis Pharmaceuticals (ticker APLS) attracts attention from biotechnology and healthcare equity investors following regulatory approvals and commercial launches of specialized therapies targeting rare retinal diseases.